Effect of Repeated Remote Ischemic Preconditioning on Peripheral Arterial Disease in Patients Suffering from Intermittent Claudication

Overview

Journal Cardiovasc Ther

Publisher Hindawi

Date 2020 Jan 4

PMID 31897086

Citations 3

Authors

Mehmet Balin

Tarik Kivrak

Affiliations

Soon will be listed here.

Abstract

Background/objective: Intermittent claudication (IC) is the symptom of peripheral artery disease (PAD) and causes functional disability. Remote ischemic preconditioning (RIPC), is a phenomenon in which a short period of sub-critical ischemia, protects tissues against ischemia/reperfusion/injury. We considered to test the hypothesis that RIPC in PAD patients suffering from IC would increase muscle resistance to ischemia and thus improve walking-capacity.

Materials/methods: A total of 63 patients with proven-IC underwent two treadmill tests (graded treadmill protocol) with a 28-day interval in between. Patients were consecutively assigned for the non/RIPC-group and RIPC-group procedure one by one. Patients received 5-cycles of alternating 5-minute inflation and 5-minute deflation of blood-pressure cuffs on nondominant upper-limb every day for four weeks. Initial claudication distance (ICD), total walking distance (TWD) and time to relief of claudication (TRC) were recorded during procedure.

Results: Patients receiving-RIPC exhibited a marked increase in ICD and TWD between basal and last tests: 209.1 ± 15.4 m vs. 226 ± 15.0 m and 368.8 ± 21.0 m vs. 394 ± 19.9 m, respectively ( < 0.001). In addition, patients receiving-RIPC represented a significant decrease in TRC between basal and last tests: 7.8 ± 1.3 min vs. 6.4 ± 1.1 min, respectively ( < 0.001). Patients not receiving-RIPC did not exhibit improvement in ICD, TWD, and TRC between basal and last tests: 205.2 ± 12.1 min vs. 207.4 ± 9.9 min, 366.5 ± 24.2 min vs. 369.4 ± 23.2 min and 7.9 ± 1.4 min vs. 7.7 ± 1.3 min, respectively ( > 0.05).

Conclusion: A significant increase in ICD and TWD were observed in last/treadmill test in RIPC-group. In addition, a significant decrease in TRC was observed in last/treadmill test in RIPC-group. In non/RIPC-group, no improvement was observed in ICD, TWD and TRC.

Citing Articles

Micro- and Macrovascular Effects of Inflammation in Peripheral Artery Disease-Pathophysiology and Translational Therapeutic Approaches.

Poledniczek M, Neumayer C, Kopp C, Schlager O, Gremmel T, Jozkowicz A Biomedicines. 2023; 11(8).

PMID: 37626780 PMC: 10452462. DOI: 10.3390/biomedicines11082284.

Repetitive application of remote ischemic conditioning (RIC) in patients with peripheral arterial occlusive disease (PAOD) as a non-invasive treatment option: study protocol for a randomised controlled clinical trial.

Hummitzsch L, Voelckers L, Rusch M, Cremer J, Albrecht M, Rusch R BMC Cardiovasc Disord. 2022; 22(1):353.

PMID: 35927627 PMC: 9351196. DOI: 10.1186/s12872-022-02795-3.

Safety and Feasibility Assessment of Repetitive Vascular Occlusion Stimulus (RVOS) Application to Multi-Organ Failure Critically Ill Patients: A Pilot Randomised Controlled Trial.

Chhetri I, Hunt J, Mendis J, Forni L, Kirk-Bayley J, White I J Clin Med. 2022; 11(14).

PMID: 35887701 PMC: 9316533. DOI: 10.3390/jcm11143938.

References

Murry C, Jennings R, Reimer K . Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986; 74(5):1124-36. DOI: 10.1161/01.cir.74.5.1124. View

Murray G, Butcher I, Heald C, Lee R, Chambless L, Folsom A . Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008; 300(2):197-208. PMC: 2932628. DOI: 10.1001/jama.300.2.197. View

Loukogeorgakis S, Williams R, Panagiotidou A, Kolvekar S, Donald A, Cole T . Transient limb ischemia induces remote preconditioning and remote postconditioning in humans by a K(ATP)-channel dependent mechanism. Circulation. 2007; 116(12):1386-95. DOI: 10.1161/CIRCULATIONAHA.106.653782. View

Tendera M, Aboyans V, Bartelink M, Baumgartner I, Clement D, Collet J . ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and.... Eur Heart J. 2011; 32(22):2851-906. DOI: 10.1093/eurheartj/ehr211. View

Hirsch A, Haskal Z, Hertzer N, Bakal C, Creager M, Halperin J . ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for.... Circulation. 2006; 113(11):e463-654. DOI: 10.1161/CIRCULATIONAHA.106.174526. View

Mozaffarian D, Benjamin E, Go A, Arnett D, Blaha M, Cushman M . Executive Summary: Heart Disease and Stroke Statistics--2016 Update: A Report From the American Heart Association. Circulation. 2016; 133(4):447-54. DOI: 10.1161/CIR.0000000000000366. View

Kumbhani D, Steg P, Cannon C, Eagle K, Smith Jr S, Goto S . Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry. Eur Heart J. 2014; 35(41):2864-72. PMC: 4216432. DOI: 10.1093/eurheartj/ehu080. View

Sieminski D, Gardner A . The relationship between free-living daily physical activity and the severity of peripheral arterial occlusive disease. Vasc Med. 1998; 2(4):286-91. DOI: 10.1177/1358863X9700200402. View

Gedik N, Maciel L, Schulte C, Skyschally A, Heusch G, Kleinbongard P . Cardiomyocyte mitochondria as targets of humoral factors released by remote ischemic preconditioning. Arch Med Sci. 2017; 13(2):448-458. PMC: 5332452. DOI: 10.5114/aoms.2016.61789. View

10.

Przyklenk K . Efficacy of cardioprotective 'conditioning' strategies in aging and diabetic cohorts: the co-morbidity conundrum. Drugs Aging. 2011; 28(5):331-43. DOI: 10.2165/11587190-000000000-00000. View

11.

Khaira H, Hanger R, Shearman C . Quality of life in patients with intermittent claudication. Eur J Vasc Endovasc Surg. 1996; 11(1):65-9. DOI: 10.1016/s1078-5884(96)80136-5. View

12.

Delagarde H, Ouadraougo N, Grall S, Macchi L, Roy P, Abraham P . Remote ischaemic preconditioning in intermittent claudication. Arch Cardiovasc Dis. 2015; 108(10):472-9. DOI: 10.1016/j.acvd.2015.03.004. View

13.

Kharbanda R, Mortensen U, White P, Kristiansen S, Schmidt M, Hoschtitzky J . Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation. 2002; 106(23):2881-3. DOI: 10.1161/01.cir.0000043806.51912.9b. View

14.

Takaoka A, Nakae I, Mitsunami K, Yabe T, Morikawa S, Inubushi T . Renal ischemia/reperfusion remotely improves myocardial energy metabolism during myocardial ischemia via adenosine receptors in rabbits: effects of "remote preconditioning". J Am Coll Cardiol. 1999; 33(2):556-64. DOI: 10.1016/s0735-1097(98)00559-2. View

15.

Stewart K, Hiatt W, Regensteiner J, Hirsch A . Exercise training for claudication. N Engl J Med. 2002; 347(24):1941-51. DOI: 10.1056/NEJMra021135. View

16.

Ren C, Yan Z, Wei D, Gao X, Chen X, Zhao H . Limb remote ischemic postconditioning protects against focal ischemia in rats. Brain Res. 2009; 1288:88-94. PMC: 2744502. DOI: 10.1016/j.brainres.2009.07.029. View

17.

Thielmann M, Kottenberg E, Boengler K, Raffelsieper C, Neuhaeuser M, Peters J . Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest. Basic Res Cardiol. 2010; 105(5):657-64. DOI: 10.1007/s00395-010-0104-5. View

18.

McDermott M . Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia. Circ Res. 2015; 116(9):1540-50. PMC: 4410164. DOI: 10.1161/CIRCRESAHA.114.303517. View

19.

Basalay M, Barsukevich V, Mastitskaya S, Mrochek A, Pernow J, Sjoquist P . Remote ischaemic pre- and delayed postconditioning - similar degree of cardioprotection but distinct mechanisms. Exp Physiol. 2012; 97(8):908-17. PMC: 3470925. DOI: 10.1113/expphysiol.2012.064923. View

20.

Przyklenk K, Bauer B, Ovize M, Kloner R, Whittaker P . Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation. 1993; 87(3):893-9. DOI: 10.1161/01.cir.87.3.893. View